NL8202773A - Apap-antizuur-samenstelling. - Google Patents

Apap-antizuur-samenstelling. Download PDF

Info

Publication number
NL8202773A
NL8202773A NL8202773A NL8202773A NL8202773A NL 8202773 A NL8202773 A NL 8202773A NL 8202773 A NL8202773 A NL 8202773A NL 8202773 A NL8202773 A NL 8202773A NL 8202773 A NL8202773 A NL 8202773A
Authority
NL
Netherlands
Prior art keywords
apap
therapeutic dose
tablet
dose according
present
Prior art date
Application number
NL8202773A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8202773A publication Critical patent/NL8202773A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8202773A 1981-07-13 1982-07-08 Apap-antizuur-samenstelling. NL8202773A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28256581A 1981-07-13 1981-07-13
US28256581 1981-07-13

Publications (1)

Publication Number Publication Date
NL8202773A true NL8202773A (nl) 1983-02-01

Family

ID=23082085

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8202773A NL8202773A (nl) 1981-07-13 1982-07-08 Apap-antizuur-samenstelling.

Country Status (17)

Country Link
JP (1) JPS5823617A (sv)
KR (1) KR840000234A (sv)
AR (1) AR228661A1 (sv)
AU (1) AU8436082A (sv)
BE (1) BE893827A (sv)
CA (1) CA1182049A (sv)
DE (1) DE3226178A1 (sv)
DK (1) DK309282A (sv)
FR (1) FR2509174A1 (sv)
GB (1) GB2103087A (sv)
GR (1) GR76197B (sv)
IT (1) IT1148199B (sv)
NL (1) NL8202773A (sv)
NO (1) NO822385L (sv)
PT (1) PT75234B (sv)
SE (1) SE8204288L (sv)
ZA (1) ZA823760B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
AU5882298A (en) * 1997-01-29 1998-08-18 Chong Kun Dang Corporation New analgesic composition
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20070298096A1 (en) * 2004-10-28 2007-12-27 Rong Liu Analgesic/Antipyretic Compositions for Enhanced Absorption
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241201A (en) * 1968-07-23 1971-08-04 Sterling Winthrop Group Ltd Improvements in or relating to effervescent pharmaceutical compositions
GB1221038A (en) * 1969-09-18 1971-02-03 H & T Kirby & Company Ltd Improvements in effervescent tablet compositions
GB1359614A (en) * 1971-04-06 1974-07-10 Dev Et De Rech Soc Fr De Method for the manufacture of effervescent tablets

Also Published As

Publication number Publication date
GB2103087A (en) 1983-02-16
PT75234B (en) 1985-10-04
KR840000234A (ko) 1984-02-18
DE3226178A1 (de) 1983-01-20
IT8248788A0 (it) 1982-07-09
SE8204288L (sv) 1983-01-14
BE893827A (fr) 1983-01-12
CA1182049A (en) 1985-02-05
SE8204288D0 (sv) 1982-07-12
FR2509174A1 (fr) 1983-01-14
JPS5823617A (ja) 1983-02-12
IT1148199B (it) 1986-11-26
AR228661A1 (es) 1983-03-30
PT75234A (en) 1982-08-01
DK309282A (da) 1983-01-14
ZA823760B (en) 1983-03-30
GR76197B (sv) 1984-08-03
NO822385L (no) 1983-01-14
AU8436082A (en) 1983-01-20

Similar Documents

Publication Publication Date Title
US5051263A (en) Controlled-release formulations
TW576743B (en) Extended release formulations of erythromycin derivatives
DE4225730C2 (de) Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
AT392901B (de) Verfahren zur herstellung einer granulaeren form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
DE69902893T2 (de) Schnellauflösende efavirenz-kapseln oder tabletten durch verwendung von super-zersetzern
AU2001260212C1 (en) Composition
NZ201008A (en) Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient
RU2241460C2 (ru) Фармацевтическая композиция цефуроксим аксетила с маскированным горьким вкусом
CA2130487A1 (en) Fast soluble tablet
HU211236A9 (en) Antacide compositions with prolonged gastric residence time
EA001918B1 (ru) Таблетка для глотания, включающая в себя парацетамол
DE69111574T2 (de) Polycarbophil-Kalzium enthaltendes Arzneimittel.
JP2003528905A (ja) スタブジン含有持続放出性ビーズ剤
CH669523A5 (sv)
NL8202773A (nl) Apap-antizuur-samenstelling.
JPH0428685B2 (sv)
TWI630911B (zh) 包含異菸鹼醯胺（ｉｓｏｎｉａｚｉｄ）顆粒及利福噴丁（ｒｉｆａｐｅｎｔｉｎｅ）顆粒之可分散錠劑型態的抗肺結核穩定醫藥組合物及其製備方法
RU2411035C2 (ru) Лекарственная форма с модифицированным высвобождением 6-метил-2-этил-3-гидроксипиридина сукцината
WO2003015807A1 (en) Side effct-relieving agents and/or hypoglycemic effect enhancers for thiazolidine derivatives
RU2245157C2 (ru) Биологически активная добавка для профилактики и лечения гриппа "фитогриппин"
KR20040091135A (ko) 염산 필지카이니드 함유 정제(건식)
JP2688266B2 (ja) アルドース還元酵素阻害作用を有し且つ吸収性の良好な薬剤組成物
Darshanam et al. Design and Development, In vitro Characterization of Gastro Retentive Floating Tablets of Anti-Ulcer Drug
KR960006061B1 (ko) 약제학적 서방성 매트릭스 및 제조방법
KR20040071587A (ko) 경구 소아용 트리메토벤즈아미드 제제 및 방법

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed